NYSE Euronext Announces Trading Volumes For June 2013

Global Derivatives ADV Up 33% Year-over-Year and Up 16% Sequentially, Ex Bclear
European and U.S. Cash Equities ADV Declined Year-over-Year but Increased Sequentially

NYSE Euronext (NYX) today announced trading volumes for its global derivatives and cash equities exchanges for June 2013¹. Global derivatives average daily volume (“ADV”) of 8.7 million contracts, excluding Bclear in June 2013 increased 32.6% compared to June 2012 and increased 15.7% from May 2013. U.S. equity options volumes remained strong in June 2013 increasing 24.0% compared to June 2012 and increasing 3.3% sequentially. ADV in U.S. cash equities declined 2.2% year-over-year, but increased 18.6% month-over-month. European cash equities ADV in June 2013 decreased 9.1% compared to June 2012, but increased 8.0% from May 2013 levels.

Highlights

NYSE Euronext global derivatives ADV in June 2013 of 8.7 million contracts increased 32.6% from June 2012, and increased 15.7% from May 2013 levels.
NYSE Euronext European derivatives products ADV in June 2013 of 4.2 million contracts, excluding Bclear, increased 44.2% compared to June 2012, and increased 31.6% from May 2013 levels. Including Bclear, NYSE Liffe’s trade administration and clearing service for OTC products, European derivatives ADV increased 3.7% compared to June 2012, and increased 21.4% from May 2013.
NYSE Euronext U.S. equity options (NYSE Arca and NYSE Amex Options) ADV of 4.5 million contracts in June 2013 increased 24.0% compared to June 2012 levels, and increased 3.3% from May 2013 levels. NYSE Euronext’s U.S. options exchanges accounted for 27.5% of total U.S. consolidated equity options trading in June 2013, up from 25.6% in June 2012, and up from 27.2% in May 2013.
NYSE Liffe U.S. ADV of approximately 96,400 contracts increased from 90,900 contracts in June 2012, and increased from 50,000 contracts in May 2013.
NYSE Euronext European cash products ADV of 1.5 million transactions in June 2013 decreased 9.1% compared to June 2012, but increased 8.0% compared to May 2013.
NYSE Euronext U.S. cash products (NYSE, NYSE Arca and NYSE MKT) handled ADV of 1.8 billion shares in June 2013 decreased 2.2% compared to June 2012, but increased 18.6% compared to May 2013. NYSE Euronext’s Tape A matched market share in June 2013 was 32.4%, down slightly from 32.5% in June 2012, but up from 30.0% in May 2013.
The preliminary average net revenue per transaction type (as defined below) for each of the primary trading venues in the second quarter of 2013 is included below:

			Preliminary
Trading Venue	2Q12	1Q13	2Q13
European Derivatives (ex. Bclear)¹	$0.674	$0.622	$0.61
U.S. Derivatives²	$0.150	$0.150	$0.15
European Cash³	$0.519	$0.620	$0.55
U.S. Cash⁴	$0.043	$0.043	$0.04
¹ Average net revenue per contract, excluding Bclear.
² Average net revenue per contract. Excludes NYSE Liffe U.S. trading volume.
³ Average net revenue per transaction.
⁴ Average net revenue per 100 shares handled.

Other Metrics

The average EUR/USD exchange rate for the second quarter of 2013 of $1.31 represented a decrease of 1.1% from the first quarter of 2013 and an increase of 1.7% compared to the second quarter of 2012. The average GBP/USD exchange rate for the second quarter of 2013 of $1.54 represented a decrease of 1.1% from the first quarter of 2013 and a decrease of 3.0% compared to the second quarter of 2012.

________________________________

¹ All NYSE Euronext derivatives transactions count buy and sell orders together as a single transaction. NYSE Euronext European equities transactions count each buy and sell order as separate transactions, NYSE Euronext U.S. equities transactions count buy and sell orders together as a single transaction.

About NYSE Euronext

NYSE Euronext (NYX) is a leading global operator of financial markets and provider of innovative trading technologies. The company's exchanges in Europe and the United States trade equities, futures, options, fixed-income and exchange-traded products. With approximately 8,000 listed issues (excluding European Structured Products), NYSE Euronext's equities markets - the New York Stock Exchange, NYSE Euronext, NYSE MKT, NYSE Alternext and NYSE Arca - represent one-third of the world’s equities trading, the most liquidity of any global exchange group. NYSE Euronext also operates NYSE Liffe, one of the leading European derivatives businesses and the world's second-largest derivatives business by value of trading. The company offers comprehensive commercial technology, connectivity and market data products and services through NYSE Technologies. NYSE Euronext is in the S&P 500 index. For more information, please visit: http://www.nyx.com.

Please follow us at:

Exchanges Blog
Facebook
LinkedIn
Twitter

CAUTIONARY STATEMENT REGARDING FORWARD LOOKING STATEMENTS

This written communication contains “forward-looking statements” made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. In some cases, you can identify forward-looking statements by words such as “may,” “hope,” “will,” “should,” “expect,” “plan,” “anticipate,” “intend,” “believe,” “estimate,” “predict,” “potential,” “continue,” “could,” “future” or the negative of those terms or other words of similar meaning. You should carefully read forward-looking statements, including statements that contain these words, because they discuss our future expectations or state other “forward-looking” information. Forward-looking statements are subject to numerous assumptions, risks and uncertainties which change over time. ICE Group, ICE and NYSE Euronext caution readers that any forward-looking statement is not a guarantee of future performance and that actual results could differ materially from those contained in the forward-looking statement.

Forward-looking statements include, but are not limited to, statements about the benefits of the proposed merger involving ICE Group, ICE and NYSE Euronext, including future financial results, ICE’s and NYSE Euronext’s plans, objectives, expectations and intentions, the expected timing of completion of the transaction and other statements that are not historical facts. Important factors that could cause actual results to differ materially from those indicated by such forward-looking statements are set forth in ICE’s and NYSE Euronext’s filings with the U.S. Securities and Exchange Commission (the “SEC”). These risks and uncertainties include, without limitation, the following: the inability to close the merger in a timely manner; the failure to satisfy other conditions to completion of the merger, including receipt of required regulatory and other approvals; the failure of the proposed transaction to close for any other reason; the possibility that any of the anticipated benefits of the proposed transaction will not be realized; the risk that integration of NYSE Euronext’s operations with those of ICE will be materially delayed or will be more costly or difficult than expected; the challenges of integrating and retaining key employees; the effect of the announcement of the transaction on ICE’s, NYSE Euronext’s or the combined company’s respective business relationships, operating results and business generally; the possibility that the anticipated synergies and cost savings of the merger will not be realized, or will not be realized within the expected time period; the possibility that the merger may be more expensive to complete than anticipated, including as a result of unexpected factors or events; diversion of management’s attention from ongoing business operations and opportunities; general competitive, economic, political and market conditions and fluctuations; actions taken or conditions imposed by the United States and foreign governments or regulatory authorities; and adverse outcomes of pending or threatened litigation or government investigations. In addition, you should carefully consider the risks and uncertainties and other factors that may affect future results of the combined company, as are described in the section entitled “Risk Factors” in the joint proxy statement/prospectus filed by ICE Group with the SEC, and as described in ICE’s and NYSE Euronext’s respective filings with the SEC that are available on the SEC’s web site located at www.sec.gov, including the sections entitled “Risk Factors” in ICE’s Form 10-K for the fiscal year ended December 31, 2012, as filed with the SEC on February 6, 2013, and “Risk Factors” in NYSE Euronext’s Form 10-K for the fiscal year ended December 31, 2012, as filed with the SEC on February 26, 2013. You should not place undue reliance on forward-looking statements, which speak only as of the date of this written communication. Except for any obligations to disclose material information under the Federal securities laws, ICE Group, ICE and NYSE Euronext undertake no obligation to publicly update any forward-looking statements to reflect events or circumstances after the date of this written communication.

IMPORTANT INFORMATION ABOUT THE PROPOSED TRANSACTION AND WHERE TO FIND IT

This communication does not constitute an offer to sell or the solicitation of an offer to buy any securities or a solicitation of any vote or approval. In connection with the proposed transaction, ICE Group has filed with the SEC a registration statement on Form S−4, which the SEC has declared effective and which contains a joint proxy statement/prospectus with respect to the proposed acquisition of NYSE Euronext by ICE Group. The final joint proxy statement/prospectus has been delivered to the stockholders of ICE and NYSE Euronext. INVESTORS AND SECURITY HOLDERS OF BOTH ICE AND NYSE EURONEXT ARE URGED TO READ THE JOINT PROXY STATEMENT/PROSPECTUS REGARDING THE PROPOSED TRANSACTION CAREFULLY AND IN ITS ENTIRETY, INCLUDING ANY DOCUMENTS PREVIOUSLY FILED WITH THE SEC AND INCORPORATED BY REFERENCE INTO THE JOINT PROXY STATEMENT/PROSPECTUS, AS WELL AS ANY AMENDMENTS OR SUPPLEMENTS TO THOSE DOCUMENTS, BECAUSE IT CONTAINS IMPORTANT INFORMATION REGARDING ICE, NYSE EURONEXT AND THE PROPOSED TRANSACTION. Investors and security holders may obtain a free copy of the joint proxy statement/prospectus, as well as other filings containing information about ICE and NYSE Euronext, without charge, at the SEC’s website at http://www.sec.gov. Investors may also obtain these documents, without charge, from ICE’s website at http://www.theice.com and from NYSE Euronext’s website at http://www.nyx.com.

NYSE Euronext
Monthly Volume Summary

		Average Daily Volume			Total Volume			Average Daily Volume		Total Volume
									% Chg vs.		% Chg vs.
(Unaudited; contracts in thousands)		Jun-13	Jun-12	% Chg	Jun-13	Jun-12	% Chg	YTD 2013	YTD 2012	YTD 2013	YTD 2012

Number of Trading Days - European Cash		20	21		20	21		125		125
Number of Trading Days - European Derivatives		20	21		20	21		126		126
Number of Trading Days - U.S. Markets		20	21		20	21		124		124

European Derivatives Products		4,769	4,597	3.7%	95,386	96,544	-1.2%	4,278	7.4%	539,024	5.7%
of which Bclear		612	1,714	-64.3%	12,244	35,998	-66.0%	815	-32.1%	102,666	-33.1%

Total Fixed Income Products		3,257	1,924	69.3%	65,138	40,401	61.2%	2,604	39.8%	328,087	37.6%

Short Term Interest Rate Products		3,059	1,783	71.5%	61,179	37,451	63.4%	2,416	41.3%	304,398	39.0%
Medium and Long Term Interest Rate Products ¹		198	140	40.9%	3,959	2,950	34.2%	188	23.6%	23,689	21.7%

Total Equity Products ²		1,416	2,592	-45.4%	28,313	54,432	-48.0%	1,584	-22.4%	199,534	-23.6%

Individual Equity Products		748	2,005	-62.7%	14,960	42,111	-64.5%	1,047	-31.7%	131,980	-32.8%
Futures		390	1,517	-74.3%	7,809	31,854	-75.5%	633	-39.6%	79,755	-40.5%
Options		358	488	-26.8%	7,151	10,257	-30.3%	414	-14.7%	52,226	-16.0%
Equity Index Products		668	587	13.8%	13,353	12,321	8.4%	536	5.9%	67,554	4.2%

of which Bclear		611	1,714	-64.3%	12,227	35,998	-66.0%	814	-32.2%	102,525	-33.2%
Individual Equity Products		468	1,621	-71.1%	9,358	34,044	-72.5%	703	-37.5%	88,633	-38.5%
Futures		385	1,512	-74.5%	7,709	31,759	-75.7%	613	-40.0%	77,299	-41.0%
Options		82	109	-24.2%	1,649	2,284	-27.8%	90	-11.8%	11,334	-13.2%
Equity Index Products		143	93	54.1%	2,869	1,955	46.8%	110	48.0%	13,892	45.7%

Commodity Products		97	82	18.8%	1,936	1,712	13.1%	90	13.3%	11,403	11.5%

U.S. Derivatives Products

Equity Options ³

NYSE Euronext Options Contracts		4,493	3,624	24.0%	89,863	76,103	18.1%	4,306	7.1%	533,914	6.2%
Total Consolidated Options Contracts		16,345	14,183	15.2%	326,896	297,841	9.8%	15,445	0.3%	1,915,146	-0.5%

NYSE Group Share of Total		27.5%	25.6%		27.5%	25.6%		27.9%	1.8%	27.9%	1.8%

NYSE Liffe U.S.

Futures and Futures Options Volume*		96.3	90.9	6.0%	1,926	1,908	0.9%	61.0	-28.0%	7,752.8	-29.1%

European Cash Products (trades in thousands)		1,516	1,668	-9.1%	30,321	35,034	-13.5%	1,424	-13.4%	178,020	-14.8%

Equities		1,461	1,617	-9.7%	29,211	33,966	-14.0%	1,372	-13.8%	171,551	-15.1%
Exchange-Traded Funds		17	14	28.1%	350	287	22.0%	14	-1.2%	1,780	-2.8%
Structured Products		33	32	4.1%	662	668	-0.8%	32	-4.7%	4,030	-6.2%
Bonds		5	5	-9.4%	98	114	-13.8%	5	6.6%	658	4.9%

U.S. Cash Products (shares in millions) ⁵		1,811	1,852	-2.2%	36,229	38,902	-6.9%	1,587	-12.0%	196,764	-12.7%

NYSE Listed (Tape A) Issues ⁴

Handled Volume ⁵		1,278	1,335	-4.3%	25,559	28,040	-8.8%	1,138	-11.8%	141,077	-12.5%
Matched Volume ⁶		1,236	1,277	-3.2%	24,710	26,813	-7.8%	1,096	-10.3%	135,865	-11.0%
Total NYSE Listed Consolidated Volume		3,809	3,930	-3.1%	76,171	82,527	-7.7%	3,597	-8.0%	446,022	-8.7%

Share of Total Consolidated Volume
Handled Volume ⁵		33.6%	34.0%	-0.4%	33.6%	34.0%	-0.4%	31.6%	-1.4%	31.6%	-1.4%
Matched Volume ⁶		32.4%	32.5%	-0.1%	32.4%	32.5%	-0.1%	30.5%	-0.8%	30.5%	-0.8%

NYSE Arca, MKT and Regional (Tape B) Listed Issues

Handled Volume ⁵		353	291	21.2%	7,054	6,110	15.5%	256	-5.9%	31,764	-6.6%
Matched Volume ⁶		324	264	22.9%	6,484	5,542	17.0%	236	-3.3%	29,258	-4.1%
Total NYSE Arca & MKT Listed Consolidated Volume		1,497	1,215	23.2%	29,933	25,507	17.4%	1,125	-2.7%	139,508	-3.4%

Share of Total Consolidated Volume
Handled Volume ⁵		23.6%	24.0%	-0.4%	23.6%	24.0%	-0.4%	22.8%	-0.8%	22.8%	-0.8%
Matched Volume ⁶		21.7%	21.7%	0.0%	21.7%	21.7%	0.0%	21.0%	-0.1%	21.0%	-0.1%

Nasdaq Listed (Tape C) Issues

Handled Volume ⁵		181	226	-20.1%	3,616	4,752	-23.9%	193	-20.2%	23,923	-20.8%
Matched Volume ⁶		162	196	-17.3%	3,237	4,109	-21.2%	172	-16.3%	21,368	-16.9%
Total Nasdaq Listed Consolidated Volume		1,879	1,790	5.0%	37,590	37,595	0.0%	1,801	0.1%	223,295	-0.7%

Share of Total Consolidated Volume
Handled Volume ⁵		9.6%	12.6%	-3.0%	9.6%	12.6%	-3.0%	10.7%	-2.7%	10.7%	-2.7%
Matched Volume ⁶		8.6%	10.9%	-2.3%	8.6%	10.9%	-2.3%	9.6%	-1.8%	9.6%	-1.8%

Exchange-Traded Products ^5,7

Handled Volume ⁵		321	271	18.6%	6,422	5,684	13.0%	241	-6.3%	29,827	-7.1%
Matched Volume ⁶		294	245	20.0%	5,876	5,140	14.3%	221	-3.6%	27,455	-4.4%
Total ETF Consolidated Volume		1,444	1,181	22.3%	28,873	24,792	16.5%	1,085	-3.6%	134,573	-4.3%

Share of Total Consolidated Volume
Handled Volume ⁵		22.2%	22.9%	-0.7%	22.2%	22.9%	-0.7%	22.2%	-0.7%	22.2%	-0.7%
Matched Volume ⁶		20.4%	20.7%	-0.3%	20.4%	20.7%	-0.3%	20.4%	0.0%	20.4%	0.0%


¹	Data includes currency products.
²	Includes all trading activities for Bclear, NYSE Liffe's clearing service for wholesale derivatives.
³	Includes trading in U.S. equity options contracts, not equity-index options.
⁴	Includes all volume executed in NYSE Group crossing sessions.
⁵	Represents the total number of shares of equity securities and ETFs internally matched on the NYSE Group's exchanges or routed to and executed at an external market center. NYSE Arca routing includes odd-lots.
⁶	Represents the total number of shares of equity securities and ETFs executed on the NYSE Group's exchanges.
⁷	Data included in previously identified categories.
^*	ADVs calculated with the appropriate number of NYSE Liffe U.S. trading days.
	Source: NYSE Euronext, Options Clearing Corporation and Consolidated Tape as reported for equity securities.
	All trading activity is single-counted, except European cash trading which is double counted to include both buys and sells.

Source: NYSE Euronext